Iversen H K, Nielsen T H, Garre K, Tfelt-Hansen P, Olesen J
Department of Neurology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Eur J Clin Pharmacol. 1992;42(1):31-5. doi: 10.1007/BF00314916.
The aim of the present study was to compare the ability of different doses of isosorbide-5-mononitrate (5-ISMN) to cause dilatation of medium sized and small arteries, and to examine the intensity and duration of any headache produced. Ten healthy volunteers each received 3 doses of 5-ISMN and placebo on separate days. The diameters of the radial and superficial temporal arteries were repeatedly measured with high frequency ultrasound and pain was scored using a 10 point verbal scale. A clear dose-relationship was found for plasma concentrations and headache, and for changes in the diameter of the temporal artery, but not for the radial artery. It is concluded that headache after 5-ISMN is caused by arterial dilatation or by mechanisms responsible for the arterial dilatation. Ultrasound monitoring of arterial diameters is an important and sensitive tool in the evaluation of nitrates and other vasodilators.
本研究的目的是比较不同剂量的5-单硝酸异山梨酯(5-ISMN)引起中、小动脉扩张的能力,并检测所产生头痛的强度和持续时间。10名健康志愿者在不同日期分别接受3种剂量的5-ISMN和安慰剂。使用高频超声反复测量桡动脉和颞浅动脉的直径,并使用10分语言量表对疼痛进行评分。在血浆浓度与头痛之间、颞动脉直径变化之间发现了明确的剂量关系,但在桡动脉中未发现。得出的结论是,5-ISMN后的头痛是由动脉扩张或负责动脉扩张的机制引起的。动脉直径的超声监测是评估硝酸盐和其他血管扩张剂的重要且敏感的工具。